The reaction gains selectivity because the peptide thioester is positioned to react with an N-terminal cysteine's sulfur rather than relying on broad acylation chemistry. This initial transthioesterification creates a linked intermediate, which then undergoes an intramolecular S-to-N acyl shift. The second step converts the temporary sulfur-linked connection into the native peptide bond, preserving the intended sequence across the junction.
The N-terminal cysteine provides the reactive thiol required to initiate transthioesterification with the C-terminal thioester. Its placement at the beginning of one peptide segment makes the reaction occur at a planned junction between segments. After the subsequent S-to-N acyl shift, the connection becomes a native peptide bond, allowing the cysteine-containing boundary to be incorporated into the larger protein sequence.
Biological production can be limiting when a target sequence is difficult to produce in a cellular system. Native Chemical Ligation instead assembles selected peptide segments, giving researchers precise access to larger proteins and sequences that may be challenging to obtain biologically. This segment-based strategy is particularly valuable when the desired product must contain a defined sequence or modification.
A workflow begins by selecting segment boundaries that create a C-terminal thioester on one peptide and an N-terminal cysteine on the adjoining peptide. These complementary functional groups define the intended ligation junction. The segments are brought together for transthioesterification and the S-to-N acyl shift, producing the larger sequence with a native peptide connection at that site.
The method supports synthesis of defined antigens, pathogen-derived proteins, and post-translationally modified peptides. These products let investigators examine immune recognition and antibody binding using molecular targets whose sequences and modifications are specified in advance. It also enables preparation of tailored protein reagents for studying host-pathogen interactions, where precise molecular composition can be important for interpreting binding or functional results.
Products generated through this strategy can serve as controlled reagents for structural and functional experiments. In immunology, defined antigens and modified peptides can help relate molecular composition to immune recognition or antibody binding. In infection research, pathogen-derived proteins and tailored reagents provide materials for examining host-pathogen interactions while maintaining a deliberately selected protein sequence.